3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
12
Neoplasm Metastasis
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Recurrence Free Survival
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Histiocytosis
1
Fallopian Tube Neoplasms
1
Erythema
1
Endometrial Neoplasms
1
Edema
1
Colonic Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Radiotherapy, Conformal
2
Radiotherapy
2
Paclitaxel
2
Nivolumab
2
Carboplatin
2
veliparib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Platinum
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cisplatin
1
CTLA-4 Antigen
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Bronchiolo-Alveolar
×
Panitumumab
×
90 days
×
Clear all
No trials found.